Literature DB >> 19679062

MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma.

Marina de Deus Moura de Lima1, Yonara Maria Freire Soares Marques, Sérgio de Melo Alves, Vanessa Morais Freitas, Fernando Augusto Soares, Vera Cavalcanti de Araújo, Décio dos Santos Pinto, Andrea Mantesso.   

Abstract

BACKGROUND: MDM2, P53, P21(WAF1) and pAKT are proteins associated with the balance between cell death and survival. There are many hypotheses regarding the role of these proteins in salivary gland tumours. However, many molecular events that activate or inactivate regulatory genes remain unknown. The aim of this study was to evaluate and to correlate MDM2, P53, P21(WAF1) and pAKT protein expressions in adenoid cystic carcinomas (ACC).
METHODS: Twenty-two cases of ACC were evaluated by immunohistochemistry and one cell line derived from ACC was analyzed by Western Blotting and immunofluorescence techniques.
RESULTS: Strong MDM2 and pAKT, variable P53 and null P21 expressions were found in the cases analyzed, but no statistical correlation was established when comparing MDM2 and pAKT expressions in the 3 different ACC subtypes. The ACC cell line showed intense nuclear and cytoplasmatic MDM2 and pAKT expressions and null P53 and P21 expressions.
CONCLUSIONS: Results indicate that MDM2 and pAKT are related to the tumorigenesis of ACC, but they might not be directly connected to tumour progression. We also demonstrate that the pAKT pathway is active in ACC and it seems to be activating the MDM2 shuttle from the cytoplasm to the nucleus, where it phosphorylates P53 and carries it to the cytoplasm for degradation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679062     DOI: 10.1016/j.canep.2009.04.016

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  8 in total

1.  EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.

Authors:  Shioto Suzuki; Yoh Dobashi; Hiroshi Minato; Ryosuke Tajiri; Tomokazu Yoshizaki; Akishi Ooi
Journal:  Virchows Arch       Date:  2012-07-25       Impact factor: 4.064

2.  Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas.

Authors:  Felipe Nör; Kristy A Warner; Zhaocheng Zhang; Gerson A Acasigua; Alexander T Pearson; Samuel A Kerk; Joseph I Helman; Manoel Sant'Ana Filho; Shaomeng Wang; Jacques E Nör
Journal:  Clin Cancer Res       Date:  2016-08-22       Impact factor: 12.531

3.  Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma.

Authors:  Kristy A Warner; Felipe Nör; Gerson A Acasigua; Manoela D Martins; Zhaocheng Zhang; Scott A McLean; Matthew E Spector; Douglas B Chepeha; Joseph Helman; Michael J Wick; Christopher A Moskaluk; Rogerio M Castilho; Alexander T Pearson; Shaomeng Wang; Jacques E Nör
Journal:  Clin Cancer Res       Date:  2016-03-02       Impact factor: 12.531

4.  Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings.

Authors:  Orsolya Kiss; Anna-Mária Tőkés; Sándor Spisák; Anna Szilágyi; Norbert Lippai; Borbála Székely; A Marcell Szász; Janina Kulka
Journal:  Pathol Oncol Res       Date:  2014-09-21       Impact factor: 3.201

5.  Abnormal activation of the Akt signaling pathway in adenoid cystic carcinoma.

Authors:  Karla Flaviana Carneiro Castelo Branco; Andre Luis Ribeiro Ribeiro; Raíssa Pinheiro de Mendonça; João de Jesus Viana Pinheiro; Maria Sueli da Silva Kataoka; Maria Vanda Catão Arnaud; Sérgio de Melo Alves Junior
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-26       Impact factor: 2.503

Review 6.  Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis.

Authors:  Qinglin Li; Ping Huang; Chuanming Zheng; Jiafeng Wang; Minghua Ge
Journal:  Oncotarget       Date:  2017-04-25

7.  Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer.

Authors:  Jessica Bauer; Ozkan Ozden; Naomi Akagi; Timothy Carroll; Daniel R Principe; Jonas J Staudacher; Martina E Spehlmann; Lars Eckmann; Paul J Grippo; Barbara Jung
Journal:  Mol Cancer       Date:  2015-10-24       Impact factor: 27.401

8.  Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing.

Authors:  Ahmad M Alamri; Xuefeng Liu; Jan K Blancato; Bassem R Haddad; Weisheng Wang; Xiaogang Zhong; Sujata Choudhary; Ewa Krawczyk; Bhaskar V Kallakury; Bruce J Davidson; Priscilla A Furth
Journal:  Dis Model Mech       Date:  2018-01-29       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.